Evropská unie - švédština - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - live recombinant marek’s disease (md) virus, serotype 1, strain rn1250 - immunologicals för aves - kyckling - for active immunisation of one-day-old chicks to prevent mortality and clinical signs and reduce lesions caused by marek’s disease (md) virus (including very virulent md virus).

Evropská unie - švédština - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - live recombinant marek’s disease virus, serotype 1, strain rn1250; live recombinant turkey herpesvirus, expressing the vp2 protein of infectious bursal disease virus, strain vhvt013-69 - immunologicals for aves, domestic fowl, avian herpes virus (marek's disease) + avian infectious bursal disease virus (gumboro disease) + newcastle disease virus/paramyxovirus - kyckling - for active immunisation of one-day-old chicks to prevent mortality and clinical signs and reduce lesions caused by marek’s disease (md) virus (including very virulent md virus), and to prevent mortality, clinical signs and lesions caused by infectious bursal disease (ibd) virus.

Evropská unie - švédština - EMA (European Medicines Agency)

intervet international b.v. - live attenuated canine distemper virus strain onderstepoort: 105.1 – 106.5 tcid50, live recombinant canine parvovirus strain 630a: 105.1 – 106.7 tcid50 - immunologiska ämnen för canidae - dogs (small) - for the active immunisation of puppies from 4 weeks of age onwards to prevent clinical signs and mortality of canine distemper virus infection and canine parvovirus infection and to prevent viral excretion following canine distemper virus infection and following canine parvovirus infection.

Švédsko - švédština - Läkemedelsverket (Medical Products Agency)

laboratorios hipra, s.a. - infektiöst bovint rhinotrakeitvirus infektiöst bovint rhinotrakeitvirus, stam ceddel, ge tk-dubbelgendeleterat, levande - frystorkat pulver och vätska till frystorkat pulver och vätska till injektionsvätska, suspension - nöt

Evropská unie - švédština - EMA (European Medicines Agency)

bavarian nordic a/s - modifierad vaccinia ankara - bavarian nordic (mva-bn) virus - smallpox vaccine; monkeypox virus - andra virala vacciner, - active immunisation against smallpox, monkeypox and disease caused by vaccinia virus in adults (see sections 4. 4 och 5. användning av detta vaccin bör ske i enlighet med officiella rekommendationer.

Evropská unie - švédština - EMA (European Medicines Agency)

ceva-phylaxia co. ltd. - cell-associerad levande rekombinant kalkonherpesvirus (rhvt / nd) som uttrycker fusionsproteinet av newcastle-sjukdomsvirus d-26-lentogen stam - immunologicals för aves, levande virala vacciner - chicken; embryonated eggs - för aktiv immunisering av 18 dagar gamla embryonated kyckling ägg eller en daggamla kycklingar för att minska dödlighet och kliniska tecken som orsakas av newcastle disease virus och för att minska dödlighet, kliniska symtom och skador orsakade av marek ' s disease virus med en fenotyp som "våldsamma".

Evropská unie - švédština - EMA (European Medicines Agency)

intervet international b.v. - cell-associerade live rekombinant turkiet herpesvirus (stam hvp360), som uttrycker fusion protein av nd virus och vp2 protein av ibd virus - aviär herpes virus (marek ' s sjukdom) + aviär smittsamma bursal disease virus (gumboro sjukdom) + newcastle disease virus/paramyxovirus - chicken; embryonated chicken eggs - for active immunisation of one-day-old chicks or 18-19-day-old embryonated chicken eggs:to reduce mortality and clinical signs caused by newcastle disease (nd) virus,to prevent mortality and to reduce clinical signs and lesions caused by infectious bursal disease (ibd) virus,to reduce mortality, clinical signs and lesions caused by marek’s disease (md) virus.

Evropská unie - švédština - EMA (European Medicines Agency)

sanofi pasteur - chimeric yellow fever dengue virus serotype 1 (live, attenuated), chimeric yellow fever dengue virus serotype 2 (live, attenuated), chimeric yellow fever dengue virus serotype 3 (live, attenuated), chimeric yellow fever dengue virus serotype 4 (live, attenuated) - denguefeber - vacciner - dengvaxia is indicated for the prevention of dengue disease caused by dengue virus serotypes 1, 2, 3 and 4 in individuals 6 to 45 years of age with test-confirmed previous dengue infection (see sections 4. 2, 4. 4 och 4. användning av dengvaxia bör ske i enlighet med officiella rekommendationer.

Evropská unie - švédština - EMA (European Medicines Agency)

laboratorios hipra, s.a. - levande, försvagat smittsamma bursal disease virus (ibdv), stam 1052 - immunologicals för aves, tamhöns, levande virala vacciner, fjäderfä smittsam bursal disease virus (gumboro sjukdom) - chicken; embryonated chicken eggs - för aktiv immunisering av 1-day-old broiler kycklingar och embryonated broiler-kyckling ägg för att minska kliniska symtom och skador i bursa av fabricius som orsakas av mycket virulent aviär smittsamma bursal disease virus infektion.

Evropská unie - švédština - EMA (European Medicines Agency)

bavarian nordic a/s - vibrio cholerae, stam cvd-103-hgr, live - kolera - vacciner - vaxchora is indicated for active immunisation against disease caused by vibrio cholerae serogroup o1 in adults and children aged 2 years and older. detta vaccin ska användas i enlighet med officiella rekommendationer.